Analysis of efficacy, safety and prognostic factors of DAC-HAA treatment in Chinese pediatric patients with refractory or relapsed acute myeloid leukemia

por Wang, Liang, Li, Chun, Xu, Fang, Cao, Fang, Zhang, Bo, Wang, Jing, Wang, Shen, Chen, Li, Li, Na, Liao, Chenglin, Liu, Hongjun
Publicado 2021

Feasibility of high-throughput drug sensitivity screening (HDS)-guided treatment for children with refractory or relapsed acute myeloid leukemia

por Lv, Wenxiu, Chen, Tianping, Wang, Shen, Li, Chun, Zhang, Bo, Wang, Liang, Xv, Fang, Cao, Fang, Wang, Jing, Chen, Li, Liao, Chenglin, Li, Na, Liu, Hongjun
Publicado 2023